Combination of nivolumab (nivo) + ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer ...
"If the predict-resect-and-discard paradigm becomes standard of care, then obviously the responsibility then lies on the shoulders of the endoscopist rather than the pathologist," he said, adding that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results